A carregar...
Practical Approach to Use of Abiraterone in Castration Resistant Prostate Cancer
INTRODUCTION: While androgen deprivation therapy remains the primary treatment modality for patients with metastatic prostate cancer, treatment is uniformly marked by progression to castration-resistant prostate cancer (CRPC). Abiraterone is the first new drug to enter clinical practice in a series...
Na minha lista:
Main Authors: | , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
2014
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4139288/ https://ncbi.nlm.nih.gov/pubmed/24775725 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|